Kerendia is Bayer’s prescription finerenone tablet brand, used to reduce kidney and heart risks in adults with specified chronic kidney disease or heart failure.
Kerendia is Bayer’s brand of finerenone, a prescription medicine supplied as film-coated tablets for specified kidney disease and heart failure indications.
Browse prescribing information, patient instructions and treatment guides covering administration, monitoring and safety precautions. These documents are medicine resources, not equipment manuals.
Visit the official Kerendia patient website for current resources. Ask your prescriber or pharmacist about individual treatment decisions.
Selected manuals from manuals+ curated for this brand.
Common questions about manuals, registration, and support for this brand.
This category contains prescribing information and patient instructions for finerenone tablets, including administration, monitoring and safety information.
Visit the treatment resources section of the official Kerendia patient website. Your pharmacist or prescriber can also provide current prescribing information.
The official savings and support page describes available programs. The supplied Bayer guide lists +1-888-537-3634 for help paying for a Kerendia prescription; eligibility conditions apply.
Kerendia is a prescription medicine, not a device requiring equipment registration. The official site offers a separate patient support program.
Do not change your treatment based solely on an online guide. Kerendia dosing requires clinician assessment and monitoring of potassium and kidney function; consult your prescriber.